Ethambutol and viomycin.
D000293:Adolescent; D000368:Aged; D001835:Body Weight; D002675:Child, Preschool; D003523:Cycloserine / Q000627:therapeutic use; D003638:Deafness / Q000139:chemically induced; D004977:Ethambutol / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D009164:Mycobacterium Infections / Q000188:drug therapy*; D009163:Mycobacterium bovis / Q000187:drug effects; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014756:Viomycin / Q000009:adverse effects / Q000627:therapeutic use*; D014786:Vision Disorders / Q000139:chemically induced; D014792:Visual Acuity / Q000187:drug effects
D004977:Ethambutol; D003523:Cycloserine; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin